InsiderSignalSign in
← Insider buys

Todd Anderman has sold OCUL and made no open-market buys since Oct 2026

Chief Legal Officer at Ocular Therapeutix, Inc.

SEC CIK 0002039533 · Filings on SEC.gov ↗

$0Bought
$87KSold
NoneLast buy

Every filing

1 filing since Oct 2026, newest first

OCULSell

OCULAR THERAPEUTIX, INC

Chief Legal Officer

$87K−7.9%Oct 13

Filings come from SEC EDGAR. Not investment advice.